(Q46832064)

25 December 2017

title

Second-line treatment of limb-threatening diabetic foot infections with intravenous fosfomycin (English)

1 reference

25 December 2017

author name string

Stengel D

1

1 reference

25 December 2017

Görzer E

2

1 reference

25 December 2017

Schintler M

3

1 reference

25 December 2017

Legat FJ

4

1 reference

25 December 2017

Amann W

5

1 reference

25 December 2017

Pieber T

6

1 reference

25 December 2017

Ekkernkamp A

7

1 reference

25 December 2017

Graninger W

8

1 reference

25 December 2017

publication date

1 October 2005

1 reference

25 December 2017

published in

Journal of Chemotherapy

1 reference

25 December 2017

volume

17

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

527-535

1 reference

25 December 2017

Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

How frequent are diabetes-related amputations of the lower limbs in Germany? An analysis on the basis of routine data

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

A cost analysis of diabetic lower-extremity ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Target site bacterial killing of cefpirome and fosfomycin in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Patient education for preventing diabetic foot ulceration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

[Etiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections: a nationwide surveillance study].

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECOaSENS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

Introducing fosfomycin for surgical prophylaxis--emergence of resistance in aerobic faecal gram-negative bacteria of in-patients, but not among strains causing infection after elective colorectal procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.527

10.1179/JOC.2005.17.5.527

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017